title: International Cancer Conference: targeted therapies boom expected in 3-5 years.
authors.forename: Marie
authors.initials: M
authors.lastname: Gethins
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood / Q000378:metabolism*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism; D003226:Congresses as Topic; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000378:metabolism; D005060:Europe; D005260:Female; D005838:Genotype; D006801:Humans; D008545:Melanoma / Q000188:drug therapy / Q000378:metabolism; D058990:Molecular Targeted Therapy / Q000379:methods; D009369:Neoplasms / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism*; D009360:Neoplastic Cells, Circulating; D018358:Neuroendocrine Tumors / Q000188:drug therapy / Q000378:metabolism; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000378:metabolism; D057285:Precision Medicine / Q000379:methods; D013964:Thyroid Neoplasms / Q000188:drug therapy / Q000378:metabolism; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000378:metabolism
chemical_list: D014408:Biomarkers, Tumor